Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Nova Biomedical Corrects Glucose Meters Over Risk of Misassigned Patient Results
Screen retention errors can misassign patient glucose results in electronic records, leading to one reported injury and a planned software update.
Flow Cytometry
Latest
FDA Clears Ready-to-Use Flow Cytometry Tests for Leukemia and Lymphoma
The FDA clearances cover two tests for the identification and diagnosis of B-cell non-Hodgkin lymphoma, including chronic lymphocytic leukemia.
Mass Spectrometry
Latest
UW Medicine Implements Roche’s Automated Mass Spectrometry Platform for Patient Testing
The system began patient testing Nov 2, initially focusing on vitamin and hormone assays, with plans to expand into therapeutic drug monitoring and toxicology.
Immunoassay
Latest
FDA Clears Rapid Blood Test to Distinguish Bacterial From Viral Infections
The Beckman Coulter assay delivers results in as little as 15 minutes on existing immunoassay analyzers, potentially helping clinicians make faster treatment decisions.
Molecular Diagnostics
Latest
MRC Holland Launches Carrier Screening Panel for 26 Inherited Disorders
The new panel detects copy number variants and selected genetic variants, including those in complex genomic regions that can be difficult to assess with routine sequencing.
Point-of-Care
Latest
Blood Test May Detect Brain Injuries Missed by CT Scans
Researchers identified blood levels of a brain injury biomarker that could help clinicians determine which patients need additional evaluation within 24 hours of trauma.